SQUAMOUS CELL CARCINOMA OF THE LARYNX
Clinical trials for SQUAMOUS CELL CARCINOMA OF THE LARYNX explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF THE LARYNX trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF THE LARYNX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New surgical trick may prevent dangerous leaks after throat cancer surgery
Disease control Recruiting nowThis study looks at whether using a piece of the patient's own tissue (a flap) to reinforce the closure after removing the voice box can reduce the risk of a throat leak (fistula). About 102 people whose throat cancer has returned after radiation or chemoradiation will be randoml…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE LARYNX
Sponsor: Regina Elena Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New hope for rare cancer: targeted drug afatinib tested in fanconi anemia patients
Disease control Recruiting nowThis study tests a drug called afatinib in 25 adults with Fanconi anemia who have advanced head and neck cancer that cannot be removed by surgery. Afatinib is a pill that blocks a protein helping cancer grow. The goal is to see if it can shrink tumors and control the disease. Res…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE LARYNX
Phase: PHASE1, PHASE2 • Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could a 3-Week radiation course replace 6 weeks for head and neck cancer?
Disease control Recruiting nowThis study compares a standard 6-week radiation course after surgery to a shorter 3-week course for people with head and neck cancer. The goal is to see if the shorter schedule works just as well at preventing cancer from coming back. About 369 participants will be randomly assig…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE LARYNX
Phase: PHASE2, PHASE3 • Sponsor: All India Institute of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could less radiation be better for head and neck cancer?
Disease control Recruiting nowThis study is for people with head and neck cancer. It compares two types of radiation therapy: one that treats only the cancer and nearby lymph nodes (INRT) and one that treats a larger area (ENI). The goal is to see if the smaller treatment area works just as well and causes fe…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE LARYNX
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New radiation method HYDRA tested for laryngeal cancer
Disease control Recruiting nowThis early-phase trial is testing a new type of radiation called HYDRA for people with laryngeal cancer. The goal is to find the highest safe dose and see how well it controls the tumor. Eleven participants will receive different doses of radiation and complete quality-of-life su…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE LARYNX
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could less radiation be better for head and neck cancer patients?
Disease control Recruiting nowThis study tests whether giving less radiation after surgery for certain head and neck cancers can reduce long-term side effects, like trouble swallowing, without allowing the cancer to come back. About 508 adults who have had surgery and need standard post-op radiation will be r…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE LARYNX
Phase: PHASE2, PHASE3 • Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Smart radiotherapy aims to cut cancer treatment side effects
Symptom relief Recruiting nowThis study tests a new way to give radiation for head and neck cancer. Instead of a fixed plan, the radiation is adjusted daily to match changes in the patient's body. The goal is to lower side effects like trouble swallowing and dry mouth. About 40 adults with throat or voice-bo…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE LARYNX
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Chill your mouth, save your taste? new device tested during cancer radiation
Symptom relief Recruiting nowThis study tests a cooling device placed inside the mouth during radiation therapy for larynx cancer. The goal is to see if cooling can protect taste buds from radiation damage and prevent loss of taste. About 15 adults with advanced larynx cancer will try the device and report t…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE LARYNX
Phase: EARLY_PHASE1 • Sponsor: Henry Ford Health System • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Stick it out: simple tongue trick could ease radiation side effects
Symptom relief Recruiting nowThis study tests a simple technique called tongue-out radiation therapy (TORT) for people with head and neck cancer. By sticking out the tongue during treatment, the radiation dose to the mouth and throat may be lowered, potentially reducing painful side effects like trouble swal…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE LARYNX
Phase: NA • Sponsor: Yvonne Mowery • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Lab-Grown tumor clones could guide cancer therapy
Knowledge-focused Recruiting nowThis study aims to grow miniature versions of head and neck tumors, called organoids, from patient samples. Researchers will test different cancer drugs on these organoids to see which ones work best. The goal is to eventually use this approach to tailor treatments to each patien…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE LARYNX
Sponsor: Centre Francois Baclesse • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC